C3303T-F5

**Figure 1\. Pedigree diagram for family C3303T\-F5\.**

![](/media/202606/20260630205251999450.png)

# Pedigree Information

| **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1 | 3303 | m.3303C\>T | C3303T\-F5 | Chile | Skeletal myopathy, cardiomyopathy | 0 | 3 | 1999 | [10431114](https://pubmed.ncbi.nlm.nih.gov/10431114/) |  |

The **m.3303C\>T** variant in MT\-TL1 was reported in family C3303T\-F5 from Chile with skeletal myopathy, cardiomyopathy. The pedigree record reported 0 unaffected and 3 affected maternal relatives, and the carrier table includes 4 listed carriers. Homoplasmy was reported in 0/4 listed carriers; 4/4 carriers were affected, and the main clinical manifestation among affected carriers was skeletal myopathy, cardiomyopathy.

# Carrier Information

| **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1 | 3303 | m.3303C\>T | C3303T\-F5 | C3303T\-F5\-I2 | Uninf | F | N | Y | A | 25 | / | \>98% | / | / | Skeletal myopathy, cardiomyopathy |  |
| 2 | 3303 | m.3303C\>T | C3303T\-F5 | C3303T\-F5\-II1 | Fam | M | N | Y | A | 20 | / | \>98% | / | / | Skeletal myopathy |  |
| 3 | 3303 | m.3303C\>T | C3303T\-F5 | C3303T\-F5\-II2 | Fam | F | N | Y | A | 27 | / | \>98% | / | / | Skeletal myopathy |  |
| 4 | 3303 | m.3303C\>T | C3303T\-F5 | C3303T\-F5\-III1 | Fam | F | Y | Y | A | 16 | / | \>98% | / | / | Skeletal myopathy, cardiomyopathy |  |

For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).